Balaji Phosphates Limited H1 Profit Rises 45.2% to ₹11.7 Crore

Balaji Phosphates Limited reported consolidated H1 FY27 net profit of ₹11.7 crore, up 45.2% year on year. Revenue from operations rose 26.1% to ₹106.9 crore for the half year ended September 30, 2026, while operating profitability improved and shareholders approved proposed capital and acquisition-related resolutions.

What did Balaji Phosphates report for H1 FY27?

Balaji Phosphates reported consolidated revenue from operations of ₹106.9 crore for April to September 2026, compared with ₹84.7 crore in H1 FY26. Total income was also ₹106.9 crore, as other income was reported at nil for the period. The company filed the consolidated half-year results with the NSE on November 13, 2026.

Profit after tax rose to ₹11.7 crore from ₹8.0 crore in the corresponding prior-year half. Profit before tax increased to ₹15.3 crore from ₹10.9 crore. The reported earnings per share for H1 FY27 was ₹4.91, while the filing did not record separate diluted EPS for the period.

The half-year comparison indicates that profit grew faster than revenue. Revenue growth was 26.1%, while profit after tax increased 45.2%. This was accompanied by stronger operating profitability, based on the figures disclosed with the results.

How did operating profitability change during the half year?

Balaji Phosphates reported an operating margin of 16.9% for H1 FY27, compared with 14.8% in H1 FY26, an improvement of 2.1 percentage points. Operating profit rose 48.0% to ₹15.23 crore from ₹10.29 crore in the comparative period.

The company also reported profit before exceptional items and tax of ₹15.3 crore, compared with ₹10.9 crore a year earlier. No exceptional item was shown in the reported half-year data, so profit before tax remained at ₹15.3 crore.

The H1 performance was also higher than the preceding H2 FY26 period on the reported comparison. Revenue from operations was ₹85.8 crore in H2 FY26, while net profit was ₹2.2 crore and operating margin was 4.8%. These figures provide context for the higher profitability reported in the first half of FY27, although the company did not provide separate consolidated quarterly figures for the quarter ended September 30, 2026.

What capital and acquisition proposals did shareholders approve?

Balaji Phosphates shareholders approved the issue of 5,146,350 convertible warrants and 1,449,900 equity shares at the company’s 30th annual general meeting held on September 26, 2026. The warrant issue was described as amounting to ₹23.45 crore and was approved alongside other capital-structure resolutions.

Shareholders also approved the acquisition of Chatak Agro (India) Private Limited. The consideration includes the issue of 1,449,900 equity shares through a share swap and a cash component. Earlier information on the proposed transaction stated that the acquisition could be for up to ₹35 crore, subject to shareholder and regulatory approvals.

The meeting also approved the acquisition of the business undertaking of DivyaJyoti Agritech Private Limited, along with a capital increase and revised borrowing limits. The available information confirms shareholder approval of these resolutions but does not state that the Chatak Agro transaction has been completed.

The equity-share and warrant approvals are relevant to investors because they alter the company’s proposed capital structure. The disclosed material does not provide the final conversion schedule, conversion outcome, or the eventual number of shares that may be outstanding after warrants are converted.

How do these developments matter for investors and operations?

Balaji Phosphates’ H1 FY27 results show that revenue and profit both increased from the prior-year period, with operating margin expanding by 2.1 percentage points. The pace of profit growth exceeded revenue growth, supported by operating profit growth of 48.0% on the supplied figures.

The shareholder approvals add a separate corporate-development element to the earnings update. The proposed warrant issue of ₹23.45 crore represents a planned source of capital, while the Chatak Agro share-swap arrangement would involve the issuance of 14.49 lakh equity shares. Their financial and operational effect depends on implementation details not available in the disclosed material.

No share-price movement, market-capitalisation change, or investor reaction was provided with the results and corporate announcements. Investors therefore have reported financial performance and approved resolutions to assess, but not a disclosed market response to these developments.

The company did not provide consolidated quarterly numbers or a prior-year quarterly comparison for the September 2026 quarter. For investors assessing recent performance, the available comparable figures are consolidated half-year data rather than a standalone Q2 consolidated earnings release.

Conclusion

Balaji Phosphates delivered consolidated H1 FY27 revenue of ₹106.9 crore and profit after tax of ₹11.7 crore, representing year-on-year increases of 26.1% and 45.2%, respectively. The improvement in operating margin to 16.9% was a key feature of the half-year result, while shareholders also cleared capital-raising and acquisition-related proposals.

The next points to watch are the implementation of the ₹23.45 crore warrant issue, progress on the approved Chatak Agro acquisition and the equity-share issuance linked to it. Investors will also look for subsequent financial disclosures, particularly because separate consolidated quarterly figures for the September 2026 quarter were not provided.